Quest Diagnostics Incorporated Stock Price and Value Analysis

Quest Diagnostics Incorporated (NYSE:DGX) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Quest Diagnostics Incorporated to reach your target.

Target type

DGX Free Cash Flow Trend

Free Cash Flow trendline for DGX
Free Cash Flow trendline for Quest Diagnostics Incorporated
CSV

Based on historical returns, we believe that Quest Diagnostics Incorporated can grow its free cash at a rate of about 7%. That's positive!

AdvantagesDisadvantages
  • This company is very stable.
  • This company is making money at a decent rate.
  • This company has fluctuating growth.
  • This stock looks overpriced.
  • This company has a low dividend yield.

Inside the DGX Numbers

DGX Price
(Quest Diagnostics Incorporated stock price per share)
$235.22
[?] PE Ratio versus Sector 23% higher than other Healthcare stocks
[?] PE Ratio versus Industry 90% lower than other Diagnostics & Research stocks
[?] Cash Yield 3.28%
[?] Free Cash Flow Jitter 30%
[?] Dividend Yield 1% (tax impact)
Shares Shorted 3,509,407

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 3,509,407 shares shorted. With 109,804,937 shares available for purchase and an average trading volume over the past 10 trading days of 1,431,610, it would take at least 2.5 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2007 1022079 707.8
2008 1022079 847.2
2009 1022079 797.8
2010 1022079 917.0
2011 1022079 702.0
2012 1022079 1001.4
2013 1022079 462.7
2014 1022079 726.5
2015 1022079 592.0
2016 1022079 860.6
2017 1022079 905.6
2018 1022079 900.2
2019 1022079 924.8
2020 1022079 1655.8
2021 1022079 1861.8
2022 1022079 1316.4
2023 1022079 865.4
2024 1022079 922.4
2025 1022079 1452.6

Download the yearly data as CSV.

Price Versus Our Estimated Value

Every one of the 19 fiscal years we have for Quest Diagnostics Incorporated under its current filer shows positive free cash flow.

At $235.22, the price is above our fair value estimate of $206.63 for Quest Diagnostics Incorporated.

Average free cash flow over the last three years of data was $1080.1 million, and across the first three years it was $784.3 million; over the period it rose sharply.

Year-to-year variability in free cash flow is uneven, measured at 30%.

Quest Diagnostics Incorporated yields 1.41% in dividends.

Our value investing guide explains how to test these numbers against the filings themselves.

Compared With Its Sector and Industry

Its trailing P/E ratio is 23% above the average for stocks in the Healthcare sector.

Its trailing P/E ratio is 90% below the average for stocks in the Diagnostics & Research industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 1022079.

Each figure on this page comes from that filer.

Risks to This Analysis

  • This page's data was last updated on 2026-07-29. Prices and filings may have changed since.
  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in DGX

Does Quest Diagnostics Incorporated have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: DGX

This example shows how we apply the Trendshare checklist to DGX: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 235.22
    • Market cap: $26B
    • EPS: 9.41
  2. Step 2 — Valuation checks

    • P/E: 24.997
    • FCF yield: 3.3%
    • Date checked: Jul 29, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.